Chirurgie Orthopédique et Traumatologique du Membre Superieur, Hopital Edouard Herriot, Lyon, France.
Department of Orthopaedic Surgery, University of California, Los Angeles, CA, USA.
J Shoulder Elbow Surg. 2023 Jul;32(7):1494-1504. doi: 10.1016/j.jse.2023.02.124. Epub 2023 Mar 12.
Modification of total elbow arthroplasty (TEA) implants may be necessary in selected patients with substantial anatomic bone deformity or those undergoing revision surgery. The purpose of this study was to investigate the prevalence and consequences of implant modifications during TEA at our institution. We hypothesized that TEA implant modification would be more common in revisions than in primary replacements, and that it would not be associated with worse clinical outcomes or increased rates of radiographic or surgical complications directly related to the implant modification.
Elbows that had undergone TEA by any of 3 surgeons at our institution with use of intraoperative implant modification between January 1992 and October 2019 were retrospectively reviewed for the type of modification and complications. Complications were classified as definitely related, probably related, possibly related, or nonrelated to the implant's modification according to the consensus review by the 3 senior surgeons. A survey was sent out to surgeons outside of our institution to investigate whether intraoperative modification to TEA implants is a common clinical practice.
A total of 106 implant components were modified during 94 of 731 TEA procedures (13%) in 84 of 560 patients. Implant modifications were performed in 60 of 285 revision cases (21%) compared with 34 of 446 (8%) primary cases (P < .0001). These included shortening the stem in 40 (44%), bending the stem in 16 (15%), notching the stem in 16 (15%), tapering the stem in 9 (9%), and a combination of 2 or more of these modifications in 19 implants (17%). Among the 55 index surgeries available for complication analysis, 40 complications occurred in 28 index surgeries (11 primary and 17 revisions; 25 patients), making the overall complication rate 51%. Of these 40 complications, 23 were considered independent of any implant modification. Of the remaining 17 complications, 9 were considered nonrelated to the implant modification, 6 were possibly related, and 2 were probably related to the implant modification. Therefore, the complication rate possibly related or probably related to implant modification was 15% (8 of 55). No complication was classified as definitely related to the implant modification. No implant breakage or malfunction occurred after any modification. A total of 442 survey responses were received representing 29 countries, of which 144 surgeons (39%) performed modification to implants during TEA procedures.
This study confirmed our hypothesis that modification of TEA implants is not uncommon at our institution, particularly in revision arthroplasty. Surgeons should keep in mind that complications possibly related or probably related to implant modification were at minimum 15% and could have been as high as 30% if the patients lost to follow-up had all had complications. Implant modification may be necessary in some cases but should be exercised with thoughtful consideration and caution.
在某些情况下,需要对全肘人工关节置换术(TEA)植入物进行修改,例如患者存在明显的解剖学骨骼畸形,或者需要进行翻修手术。本研究旨在探讨我院 TEA 术中植入物修改的发生率和后果。我们假设在翻修手术中,TEA 植入物的修改更为常见,且不会导致临床结果恶化,也不会增加与植入物修改直接相关的放射学或手术并发症的发生率。
回顾性分析我院 3 位医生施行的 TEA 手术,术中使用植入物修改,时间为 1992 年 1 月至 2019 年 10 月。研究的内容包括修改类型和并发症。根据 3 位资深医生的共识意见,将并发症分为与植入物修改直接相关、很可能相关、可能相关或与植入物修改不相关。我们向院外医生发放了一份调查问卷,以了解 TEA 植入物的术中修改是否为一种常见的临床实践。
在我院 731 例 TEA 手术中,有 84 例患者(560 例患者中的 13%)共进行了 106 次植入物修改。在 285 例翻修手术中进行了 60 次(21%),在 446 例初次手术中进行了 34 次(8%)(P<.0001)。这些修改包括缩短柄 40 次(44%)、弯曲柄 16 次(15%)、切槽 16 次(15%)、变细柄 9 次(9%)以及 19 次使用 2 种或以上方法的组合(17%)。在 55 例可进行并发症分析的索引手术中,28 例索引手术(11 例初次手术和 17 例翻修手术;25 例患者)共发生 40 例并发症,总体并发症发生率为 51%。这 40 例并发症中,有 23 例与任何植入物修改均无关。在其余 17 例并发症中,有 9 例与植入物修改无关,6 例可能相关,2 例可能相关。因此,可能相关或可能相关的并发症发生率为 15%(8/55)。没有并发症被归类为与植入物修改直接相关。任何修改后均未发生植入物断裂或功能障碍。共收到来自 29 个国家的 442 份调查回复,其中 144 名外科医生(39%)在 TEA 手术中对植入物进行了修改。
本研究证实了我们的假设,即在我院,TEA 植入物的修改并不少见,尤其是在翻修手术中。外科医生应牢记,可能相关或可能相关的植入物修改相关并发症的发生率至少为 15%,如果失去随访的患者都出现了并发症,其发生率可能高达 30%。在某些情况下,可能需要对植入物进行修改,但应慎重考虑,并谨慎进行。